ABSTRACT. In mouse macrophage cells, the increase of the intracellular CAMP level activates protein kinase A (PKA) and results in inhibition of cell cycle progression in both Gl and G2/M phases. Gl arrest is mediated by a cdk inhibitor, p27KiP1, which prevents Gl cyclin/cdk complexes from being activated in response to colony stimulating factor-1, whereas inhibition of G2/M progression has not been fully elucidated. In this report we analyzed the effect of CAMPon G2/Mprogression in a mouse macrophage cell line, BAC1.2F5A.Flow cytometric analysis and mitotic index measurement using both synchronized and asynchronized cells revealed that addition of CAMP-elevating agents (8-bromoadenosine 3':5'-cyclic monophosphate and 3-isobutyl-methylxanthine), although they did not affect S phase progression or M/Gl transition, temporarily arrested cells in G2 but eventually the cells proceeded to Mphase, resulting in about 4 hours delay of G2 progression. Timing of cyclin Bl/Cdc2 kinase activation was also retarded by about 4 hours, which was accompanied by inhibition of efficient accumulation of cyclin Bl proteins. Initial induction and accumulation of cyclin Bl mRNAwere not hampered, but the half life of cyclin Bl proteins was significantly shorter during G2 phase in the presence of CAMP-elevating agents compared with that of the cells blocked from progressing through Mphase by nocodazole. These results imply that the CAMP/PKA pathway regulates G2 phase progression by altering the stability of a crucial cell cycle regulator.
Gl and G2/M progression (5) (6) (7) (8) . Gl arrest is now shown to be mediated by inhibition of Gl cyclin/Cdk activities either by prevention of expression of cyclin or Cdk subunits or by induction of various Cdk inhibitors (9, 10) . G2/M progression is regulated by the cyclin B/Cdc2 complex (1 1), and antiproliferative signals directly or indirectly target this kinase complex.
CAMP functions as a second messenger in the signal transduction pathway initiated by a variety of hormones (12) . Elevation of intracellular CAMPlevels induces activation of PKA (CAMP-dependent protein kinase) and all the biological effects of CAMPknown so far occur through the activation of PKA (13) Mousemacrophageshave provided a useful model system for investigations into the mechanisminvolved in both positive and negative growth control including CAMP-mediated growth inhibition (14) . CAMP-elevating agents including prostaglandin E2, 3-isobutylmethylxanthine (IBMX), and cholera toxin, as well as CAMP analogs such as dibutyryladenosine 3':5'-cyclic monophosphate and 8-bromoadenosine 3':5'-cyclic monophosphate (8Br-CAMP), inhibit proliferation of murine bone marrow-derived macrophages (BMM) (15) and a colony stimulating factor-1 (CSF-Independent murine macrophage cell line, BAC1.2F5 (6, 16) . CAMP-mediatedsignals seem to affect both Gl/S and * To whomcorrespondence should be addressed.
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G2/M progression of the macrophage cell cycle (6) . In BMM cells arrested in Gl by CAMP,expression of both cyclin Dl, the major D-type cyclin in macrophages, and
Cdk4 is suppressed (17, 18) . However, BAC1.2F5A
variants which are capable of expressing cyclin Dl and Cdk4 in the presence of CAMPare still sensitive to CAMP-mediated Gl arrest (6) , suggesting that cyclin Dl and Cdk4 are not the only targets of the CAMPpathway. In these particular cells, addition of CAMP induces the accumulation of a Cdk inhibitor, p27Kipl, which binds to and inhibits cyclin Dl/Cdk4 complexes (6) . However, the mechanism by which CAMPregulates G2/M progression remains to be investigated. The cyclin B/Cdc2 complexes play a central role in G2 and Mphase progression and are subject to multiple positive and negative regulatory mechanisms (ll, 19) . As cyclin B proteins accumulate during G2 phase, they form a complex with Cdc2, which triggers both activating and inhibiting phosphorylation on a Cdc2 subunit by CAK, Weel, and Mytl (ll, 19) . As cells approach the G2/M boundary, cyclin B/Cdc2 complexds, which are localized in the cytoplasm during G2, moveinto the nucleus and are dephosphorylated and activated by Cdc25 (ll, 19) . After metaphase/anaphase transition, cyclin B proteins are ubiquitinated by Anaphase Promoting Complex (APC) and degraded by 26S proteasome (20, 21) . Activation of cyclin B/Cdc2 complexesare absolutely necessary for cells to enter M phase (ll, 19) . Cyclin B mRNAbegins to accumulate in late S phase and reaches its maximumlevel around the G2/Mboundary, which accounts for the accumulation of cyclin B proteins during S and G2 phases. However, the levels of cyclin B mRNAgradually decline in Gl, when cyclin B proteins exist at undetectable levels. This is because once the degradation system for cyclin B proteins such as APCis activated in M phase, its activity is maintained during Gl phase (22 For flow cytometric analysis of DNA content, cells were suspended in a 1 ml solution of 0.1% sodium citrate and 0.1% Triton X-100 containing 50 /ig/ml of propidium iodide and treated with 1 /ig/ml of RNase for 30 min at room temperature. Fluorescence from the propidium iodide-DNA complex was measured with a FACScanflow cytometer (Becton Dickinson), and the percentages of cells in Gl, S, and G2/M phases of the cell cycle were determined. To specifically determine percentages of cells in mitosis (mitotic index), metaphase chromosome spreads were prepared as follows. Cells were washed with PBS, and suspended and incubated in 1 ml of 75 mMKC1 for 15 min. Then, 0.2ml of ice-cold Carnoy's fixative agent (Methanol:Acetic acid = 3 : 1 (vol/vol)) was added. Cells were collected by centrifugation and resuspended in ice-cold Carnoy's fixative agent. The cell suspension was dropped onto a wet glass slide and dried. Metaphases per total number of nuclei were counted under a light microscope.
Protein Analyses Cells were lysed in SDS-sample buffer (40 mMTris-HCl, pH 6.8, 0.1 M DTT, 1% SDS, 10% glycerol, and 0.05% Bromophenol Blue) and boiled for 4 min. The cell lysates clarified by centrifugation were separated on 10% SDS-polyacrylamide gels under reducing conditions, transferred to a PVDFmembrane (Millipore), and immunoblotted with rabbit polyclonal antibody specifically recognizing rodent cyclin Bl , but not B2 or B3 (this antibody is also capable of immunoprecipitating active cyclin Bl/Cdc2 complexes; Santa Cruz Biotechnology), followed by detection with the ECL blotting system (Amersham)according to the manufacturer's instructions. PCRamplification of cyclin B transcripts was performed with oligonucleotide primers specific for coding sequences of cyclin Bl (5'-GTGCAGATGGAGGCGCTAGC-3' and 5'-CAG GATCTGAGAAGCGCAGG-3') and cyclin B2 (5'-GAGGTG GAACTTGCTGAGCC-3' and 5'-GTTATGCCTTTGTCAC GGCC-3 ) with 28 cycles of denaturation (94°C, 1 min), annealing (60°C, l min), and extension (72°C, 2min). PCR products were electrophoresed in 1%agarose gels, visualized by staining with EtBr, and quantitatively analyzed using a Densitograph (ATTO). Specific amplification of cyclin Bl and B2 sequences was confirmed by digestion with restriction enzymes specific to each of them (Sail and Sad, respectively) and by sequencing of amplified fragments. Experiments conducted using various amounts of input template ensured that the assay wasquantitative under these conditions.
RESULTS

Effect of CAMPon G2/MProgression in Murine Macrophage Cells
The mouse macrophage cell line, BAC1.2F5A, is dependent upon CSF-1 for proliferation and survival, and remainder arrest in G2 (6) . In contrast, other inhibitors of cell cycle progression such as rapamycin block proliferating cells only in Gl phase (6) . Thus, because inhibition of G2 progression is correlated with nothing else (the solvent used to dissolve agents or any other particular structure of the chemicals) other than an activator of PKA, we concluded that activation of PKA, but not any kind of toxic effect, is responsible for G2 block. However, the amount of cells arrested in G2 differed from one experiment to another. To investigate the effect of CAMP more precisely, we added CAMP-elevating reagents (in this particular experiment shown in Fig. 1 , we used 8Br-CAMP and IBMX, but other CAMPagents exhibited the same effects; data not shown) to asynchronously growing cells and determined cell cycle distribution by flow cytometric analysis of DNAcontent every 3 hours (Fig. 1) . The population of cells in Gl phase with a 2n DNAcontent gradually increased after a short time and that of cells in S phase reciprocally decreased. In contrast, the number of cells in G2/Mphase with a 4n DNAcontent elevated during the first 9 hours after stimulation and declined thereafter.
Macrophage cells arrested in early Gl by deprivation of CSF-1 for 22 hours were stimulated with the growth factor to reenter the cell cycle synchronously and 8Br-cAMPand IBMXwere added 8 hours after stimulation, at which time CAMP was no longer able to arrest cells in Gl (data not shown, but see among which cyclin Bl plays an essential role in regulation of G2/Mtransition. Therefore we focused our attention on the effect of CAMP on the timing of cyclin Bl/Cdc2 kinase activation. Macrophage cells arrested in early Gl by CSF-1 deprivation synchronously reentered the cell cycle on stimulation with the growth factor, and 8Br-CAMPand IBMXwere added 8 hours after stimulation to exclusively examine the effect of CAMPon G2/M. Cells in G2 and M phases were harvested, and cyclin Bl/Cdc2 complexes were immunoprecipitated from each cell lysate with antibody specifically recognizing murine cyclin Bl and were assayed for their kinase activity in vitro using histone HI as a substrate (Fig. 4) . Cyclin Bl/Cdc2 kinase was maximally activated 17 hours after release in normally proliferating cells, whereas CAMP-treatment delayed its activation by about 4 hours with a peak 21 hours after release. The relatively high level of cyclin Bl/Cdc2 kinase activity observed before entering M phase was mostly due to the partial activation of the cyclin Bl/Cdc2 complex which occurred during immunoprecipitation by an unknown mechanism. However, in agreement with the results obtained from the in vitro kinase assay, loss of the inhibitory phosphorylation of the Cdc2 catalytic subunit, which can be easily and accurately detected by examining the mobility shift of Cdc2 in SDS-polyacrylamide gel electrophoresis using the direct lysates, ocurred between 15 and 17 hours after release in normally proliferating cells, but it took place between 19 and 21 hours after release in the presence of CAMP (data not shown). Thus, CAMP-treatment did delay the timing of cyclin Bl/Cdc2 kinase activation by about 4 hours, but did not sustain the high level of cyclin Bl/Cdc2 activity. The timing of maximumactivation of cyclin Bl/Cdc2 kinase in both cells coincides with the M phase peaks identified by mitotic index measurement (see Fig. 3 ). The maximumlevels of cyclin Bl/Cdc2 kinase activity were very similar in both cases.
We To directly investigate whether slow accumulation of cyclin Bl proteins is the primary cause of G2 delay, we attempted to overexpress cyclin Bl proteins in BAC1.2F5Acells. However, the transfection efficiency onto macrophage cells was about 1000 times lower than that on any other types of cells by the methods we used, which include calcium phosphate transfection, electroporation, liposome-mediated transfection, and infection with retrovirus vectors. Therefore, the extremely low transfection efficiency of macrophages prevented us from directly testing whether upregulation of cyclin Bl proteins can override the G2 delay induced by the CAMP/PKA pathway.
The accumulation of cyclin Bl mRNA was not signifi cantly affected by CAMPduring G2
To examine whether slow accumulation of cyclin Bl proteins in the presence of CAMP is due to inhibition of the cyclin Bl gene transcription or instability of cyclin Bl mRNA,we analyzed expression of cyclin Bl mRNA in synchronized cultures in the presence and absence of CAMP. To specifically detect cyclin Bl mRNA in total RNAwhich contains highly related cyclin B2 mRNA,we utilized quantitative reverse transcription and polymerase chain reaction (RT-PCR) using specific primers (Fig. 6A) . A single band was obtained by RT-PCRusing a set of primers specific to cyclin Bl or B2 CDNA sequences (lanes 1 and 6) . Nucleotide sequences of cyclin Bl and B2 CDNArevealed that the digestion sites of Sail and Sad are specifically contained, respectively, in the regions between primers. PCRproducts obtained using cyclin Bl primers were refractory to Sad digestion but completely digested by Sail (lanes 2 and 3), whereas cyclin B2 products were digested by Sad but not by Sail (lanes 4 and 5) , confirming that each RT-PCRproduct was specific to cyclin Bl or B2 mRNA. No DNAfragments were amplified without RTase (data not shown), indicating that PCR products were derived from CDNA but not from contaminated genomic DNA.The amount of PCRproducts proportionally increased as more template CDNA was used (Fig. 6B) , confirming that the PCRconditions we used are suitable for quantitative analysis. The total RNAwas isolated from synchronized cells at various times in the presence or absence of 8Br-cAMP and IBMX, and was analyzed for cyclin Bl mRNAexpression by RT-PCR using specific primers (Fig. 6C) . Very little cyclin Bl mRNAwas detected ll hours aftbr release, and its amount increased as cells progressed through G2 and Mphases. The kinetics and the amount of cyclin Bl mRNA expression are very similar until 17 hours after release in the presence and absence of CAMP, which suggests that CAMP-mediated signals do not inhibit cyclin Bl mRNA accumulation during G2 phase (between ll and 15 hours after release), whencyclin Bl proteins accumulate with slower kinetics in the presence of CAMP (see Fig. 5 ). However, it is interesting to note that cyclin Bl mRNAexpression continued to increase after entry into Mphase and peaked at around M/Gl transition, and that addition of CAMP agents seemedto prevent efficient accumulation of cyclin Bl mRNA during this period, resulting in about 2 hours delay of the maximumexpression.
Decrease of cyclin Bl protein stability during G2 by CAMP Since CAMP-treatment did not significantly alter the kinetics of cyclin Bl mRNAinduction during G2 phase (see above and Fig. 6C ) or the rates of cyclin Bl translation (data not shown), we next analyzed the stability of cyclin Bl proteins during G2 with and without CAMPtreatment (Fig. 7) . To examine the half life of cyclin Bl proteins specifically in G2, synchronized early Gl cells were stimulated to progress to late S phase (ll hours after release) by incubating them in CSF-1 , metabolically labeled with [35S]methionine for 1 hour, and chased for the times indicated in Fig. 7 Time after release from starvation measured. As cells exit from M phase, cyclin Bl proteins rapidly degrade (19) , which prevents precise measurement of the half life of cyclin Bl protein. by CAMPhas been well characterized using the macrophage cell system (6, 15, 16) . In Gl-arrested macrophages, the activity of cyclin D/Cdk4 kinase, which plays an essential role in Gl progression, is down-regulated either by preventing both subunits from being expressed (17, 18) or by inducing a Cdk inhibitor, p27KiPJ (6) . Introduction of the plasmid expressing antisense p27KiPi cdna allowed macrophage cells to progress into S phase in the presence of CAMP(J.-Y. Kato, unpublished data), suggesting that p27KiP1 plays an important role in Gl arrest mediated by CAMP.
CAMP-mediated signals appear to affect G2 progression of the macrophage cell cycle as well (6 proteins during the G2arrest induced by these agents (23) , suggesting that inhibition of cyclin Bl protein accumulation is not specific to the CAMP/PKA pathway, but could be a part of the G2 checkpoint control mechanisms. However, our results do not exclude the possibility that negative phosphorylation of the Cdc2 subunit is also involved in CAMP-mediatedG2 regulation. In Mphase, cyclin Bl proteins are rapidly degraded through ubiquitination by APC followed by proteolysis mediated by 26S proteasome (20, 21) . In fission yeast, the CAMP/PKApathway inhibits APC complex formation and activation (25) . In the mammaliansystem, Polo-like kinase and PKA positively and negatively regulate the APCactivity, respectively, by specifically phosphorylating the APCsubunits (26). The level of PKAactivity in NIH3T3cells rapidly increases at the beginning of mitosis, reaches maximumin early mitosis, and drops at metaphase (26). These results appear to indicate that activation of PKAinhibits APCactivity and prevents cyclin B degradation. However, the experiments using cycling Xenopus egg extracts indicate that activation of the CAMP/PKA pathway is required for induction of cyclin B degradation and exit from M phase (27) . Furthermore, the effect of CAMP differs from one cell type to another (12) phase maytrigger initiation of some portions of the M phase specific program, such as APCactivation, thereby preventing efficient progression from G2 to M phase. Alternatively, macrophages may express specific
